Cargando…
Sonidegib, a novel smoothened inhibitor for the treatment of advanced basal cell carcinoma
Basal cell carcinoma (BCC) is the most common nonmelanoma skin cancer. If left untreated, BCCs can become locally aggressive or even metastasize. Currently available treatments include local destruction, surgery, and radiation. Systemic options for advanced disease are limited. The Hedgehog (Hh) pat...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028081/ https://www.ncbi.nlm.nih.gov/pubmed/27695345 http://dx.doi.org/10.2147/OTT.S108171 |